SBIA
SRNE

Sheaff Brock Investment Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,850
Closed -$190K – 595
2021
Q3 		$190K Buy
24,850
+4,400
+22% +$37.3K 0.01% 503
2021
Q2 		$198K Buy
20,450
+2,850
+16% +$22.7K 0.01% 480
2021
Q1 		$146K Buy
+17,600
New +$186K 0.01% 466
2020
Q4 		– Sell
-12,100
Closed -$135K – 517
2020
Q3 		$135K Buy
+12,100
New +$111K 0.01% 421

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Sheaff Brock Investment Advisors's SRNE Position: Q4 2021 in Review

Sheaff Brock Investment Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 24,850 shares — an estimated $190K sold.

Sheaff Brock Investment Advisors first reported a position in SRNE in Q3 2020 and held it in 4 quarters. The position peaked at $198K in Q2 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • Sheaff Brock Investment Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 24,850 Sorrento Therapeutics, Inc. shares in Q4 2021, an estimated $190K.
  • Sheaff Brock Investment Advisors first reported a position in Sorrento Therapeutics, Inc. in Q3 2020 and held it in 4 quarters.
  • Sheaff Brock Investment Advisors's Sorrento Therapeutics, Inc. position peaked at $198K in Q2 2021.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.